Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-5-28
|
pubmed:abstractText |
Activin A is a homodimeric protein structurally related to transforming growth factor-beta. The present study was conducted to examine the effect of activin A on the growth of rat vascular smooth muscle cells (VSMC) in culture. When serum-deprived cells were incubated with activin A, nuclear labeling of bromodeoxyuridine occurred after a 12-h lag period. The effect of activin A on nuclear labeling was dose-dependent, being maximal at 10(-9) M. Activin A also increased the number of VSMC after 30 h of incubation. Insulin-like growth factor-1 (IGF-1) had only a small effect on nuclear labeling by itself but the effects of IGF-1 and activin A were additive. When quiescent VSMC were treated with activin A for 4 h, the effect of subsequent IGF-1 was markedly enhanced. Furthermore, activin A induced an autocrine production of IGF-1 in VSMC. In contrast to these positive effects on cell growth, activin A was rather inhibitory to the action of IGF-1 in activin-primed cells. In addition, activin A inhibited platelet-derived growth factor-induced nuclear labeling. These results indicate that activin A modifies growth of VSMC by complex mechanisms involving autocrine production of IGF-1 and modification of the action of IGF-1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Activins,
http://linkedlifedata.com/resource/pubmed/chemical/Bromodeoxyuridine,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Growth Substances,
http://linkedlifedata.com/resource/pubmed/chemical/Inhibins,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin-Like Growth Factor I,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet-Derived Growth Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0014-4827
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
206
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
152-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8482356-Activins,
pubmed-meshheading:8482356-Animals,
pubmed-meshheading:8482356-Bromodeoxyuridine,
pubmed-meshheading:8482356-Cell Division,
pubmed-meshheading:8482356-Cell Nucleus,
pubmed-meshheading:8482356-Cells, Cultured,
pubmed-meshheading:8482356-DNA,
pubmed-meshheading:8482356-Dose-Response Relationship, Drug,
pubmed-meshheading:8482356-Drug Synergism,
pubmed-meshheading:8482356-Growth Substances,
pubmed-meshheading:8482356-Inhibins,
pubmed-meshheading:8482356-Insulin-Like Growth Factor I,
pubmed-meshheading:8482356-Male,
pubmed-meshheading:8482356-Muscle, Smooth, Vascular,
pubmed-meshheading:8482356-Platelet-Derived Growth Factor,
pubmed-meshheading:8482356-Rats,
pubmed-meshheading:8482356-Rats, Wistar,
pubmed-meshheading:8482356-Time Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Modulation of growth of vascular smooth muscle cells by activin A.
|
pubmed:affiliation |
Cell Biology Research Unit, Gunma University, Maebashi, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|